Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Phigenics announces the publication of the Validation of PVT VIABLE in the Journal of AOAC INTERNATIONAL


“AOAC PTM certification focuses on evaluating new, innovative methods against industry accepted standards. PVT VIABLE® was compared to ISO 11731 in this study and the results were statistically similar; providing evidence that PVT VIABLE® is an effective and defensible strategy for the validation of Water Management Programs for potable water systems,” says Leah Wickenberg, Product Research and Development Supervisor at Phigenics.

Regarding the importance of AOAC PTM Certification, Missy Cain, VP of Technology for Phigenics states “Phigenics recognizes the importance of an AOAC PTM certification for new environmental diagnostics, notably for applications in which the test method can improve the risk management of building water systems. This PTM certification helps support organizations that have identified the need to improve historical validation strategies, while promoting the importance of test method integrity and defensibility. Phigenics will continue to support the development of innovative diagnostic products that meet AOAC INTERNATIONAL method validation requirements in order to help ensure the safety of water systems and positively impact public health.”

To read the research paper visit:
https://academic.oup.com/jaoac/advance-article/doi/10.1093/jaoacint/qsad112/7281346

PVT VIABLE® is a commercially available Legionella diagnostic, for more information on PVT VIABLE® and how it can improve your Water Management Team’s decision making and mitigate the risk of waterborne pathogens, please visit: https://info.phigenics.com/testing

About Phigenics
Phigenics sells comprehensive water management programs, innovative diagnostics, data management and automated monitoring solutions. Facility managers and building owners use these solutions to optimize the total cost of their water systems by improving safety and efficiency. Phigenics water management programs include regulatory compliance, data management, and water testing analytical services, including Legionella testing services. As a non-conflicted, third party, Phigenics provides independent verification and validation that programs are defensible and water management goals have been achieved in the most cost effective manner.

About AOAC INTERNATIONAL
AOAC INTERNATIONAL is a globally recognized, 501(c)(3), independent, third party, not-for-profit association and voluntary consensus standards developing organization founded in 1884. When analytical needs arise within a community or industry, AOAC INTERNATIONAL is the forum for finding appropriate science-based solutions through the development of microbiological and chemical standards. The AOAC Official Methods of AnalysisSM and the Performance Tested MethodsSM are used by food and environmental scientists around the world to facilitate public health and safety and to promote trade. For more information, please visit http://www.AOAC.org.

Media Contact

Kellen Utecht, Phigenics LLC, 1-844-850-4087, [email protected], https://info.phigenics.com/ 

SOURCE Phigenics LLC

Increased Anesthesia Volume May Provide Longer Pain Relief During Dental Procedures


A total of 118 healthy patients (52 male, 66 female), with an average age of 27 years, were assessed “to compare the peak incidence of success, onset, and incidence of pulpal anesthesia from 2 to 68 minutes in maxillary first molars following a buccal infiltration of 1.8 mL or 3.6 mL of 4% articaine with 1:100 000 epinephrine.” Patients were randomized into two groups and underwent two instances of receiving anesthesia spaced two weeks apart. Each patient received the 1.8- and 3.6-mL doses at the first appointment and then the opposite amount at the second to compare the results.

Woo et al. report that they found no statistical significance for the anesthetic success, which occurred between 14 and 18 minutes, for either volume. This was also true of the onset times (4.5 minutes for 1.8 mL; 4.5 for 3.4 mL). The significance occurred in the incidence of anesthesia at minute 48. The researchers found a greater decline in the incidence for the 1.8-mL volume from 48 to 68 minutes. For both the 1.8-mL and 3.4-mL volumes, the incidence began to decline at about 30 minutes, with the greatest decline happening at 48 minutes. However, 78% of patients had a higher incidence rate of pulpal anesthesia, from 48 to 68 minutes. Neither volume was successful at providing anesthesia for all subjects for 60 minutes.

This study shows that increasing the volume of anesthesia from 1.8 to 3.4 mL for lengthy dental procedures provided a longer pain control duration in procedures lasting more than 48 minutes. However, it also highlighted the need for additional action in administering additional anesthesia for longer dental procedures to ensure optimal patient comfort. Woo and colleagues state that anesthesia “reinjection could be a clinical strategy to ensure adequate anesthesia in the maxilla for procedures lasting 60 minutes or longer.”

Full text of the article, “Success of Pulpal Anesthesia Following Buccal Infiltration of the Maxillary First Molar With 1.8 mL and 3.6 mL of 4% Articaine With 1:100,000 Epinephrine: A Prospective, Randomized Crossover Study,” Anesthesia Progress, Vol. 70, No. 3, 2023, is now available at https://doi.org/10.2344/anpr-70-03-01

About Anesthesia Progress

Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites

submissions of review articles, reports on clinical techniques, case reports, and conference summaries. To learn more about the ADSA, visit: http://www.adsahome.org/.

Media Contact:

Samantha Weinkauf

Knowledge Works Global Ltd.

785/289-2649

samantha.weinkauf@kwglobal.com

SOURCE Anesthesia Progress

Damo Announces the Launch of the DigiM™ Digital Maturity Momentum Awards 2023


The DigiM™ Digital Maturity Momentum Awards are grounded in the DigiM™ Digital Maturity Framework, an invaluable tool for assessing and benchmarking digital maturity and progress within the realm of digital transformation. The awards ceremony is a recognition of excellence, a benchmarking exercise, and a platform for sharing best practices that can inspire and guide peers in the industry.

Why the DigiM™ Digital Maturity Momentum Awards Matter:

  • Recognition of Excellence: DigiM™ Award recipients are celebrated for their exceptional leadership in digital transformation, reflecting dedication and accomplishments in the field.
  • Benchmarking and Self-Reflection: The awards encourage organizations to assess their digital maturity, offering insights into strengths and areas for improvement, and fostering ongoing growth and development.
  • Sharing Best Practices: Participants have the opportunity to share their best practices and insights with a global audience, serving as valuable resources for others on their digital journey.
  • Inspiration for Others: Achievements in digital transformation can inspire and motivate others to strive for excellence, making the DigiM™ Awards a platform for sharing success stories that guide peers in the industry.

Award Categories:

Submissions for the DigiM™ Digital Maturity Momentum Awards will be evaluated in the following categories:

  • Digital Engagement Maturity: Recognizing organizations that have excelled in engaging their audiences effectively through digital channels.
  • Technology Engagement Maturity: Celebrating innovation and excellence in the implementation of digital technologies.
  • Overall Leadership in Digital Transformation Strategy and Execution: Honoring individuals, teams, or organizations that have demonstrated exceptional leadership and execution of digital transformation strategies.

“We are honored to be named an overall leader in the Damo Digital Maturity Awards program. The award is a recognition of the significant achievements and positive outcomes that we have made in digitally enabling our consumer, clinical, and employee experiences. Digital maturity is not the job of only one team in an organization. It’s a cultural shift made possible by the work of many hands – not all of them tech folks – across the care continuum. And as is true within our health systems, so too is this way of digital transformation for the American healthcare landscape: growth made possible by an ecosystem of providers and partner organizations across the country who motivate and inspire one another’s evolution,” says Emily Kagan Trenchard, Senior Vice President, Chief Consumer Digital Solutions, Northwell Health.

How to Submit Your Assessment:

To participate in the DigiM™ Awards, follow these steps:

  • Visit our online portal.
  • Complete the assessment questionnaire (20–30 minutes).
  • Ensure all required information is accurate and up to date.
  • Submit your assessment by the deadline, November 08, 2023.

The DigiM™ Awards are an online event, with winners and honorees announced in January 2024. Every participant will receive a copy of their assessment, along with an opportunity to discuss their report with our experts. Damo Consulting looks forward to celebrating achievements and connecting with a community of digital transformation enthusiasts. We encourage all participants to share this opportunity with their networks, colleagues, and peers who have made notable contributions to the digital transformation landscape.

About the DigiM™ Awards

The DigiM™ Awards is an annual awards event that celebrates excellence in digital innovation. It recognizes and honors individuals, organizations, and projects that have made significant contributions to the digital world. For more information, please visit www.damoconsulting.net.

For inquiries or further information, please contact us at [email protected].

Media Contact

Rohit Mahajan, Damo Consulting, 1 630 242 2881, [email protected], https://www.damoconsulting.net/

SOURCE Damo Consulting

Prevent Blindness Provides Informational Resources to Professionals and the Public for November’s Diabetes-related Eye Disease Awareness Month


Prevent Blindness, the nation’s leading nonprofit eye health and safety organization, has declared November as Diabetes-related Eye Disease Awareness Month, providing the public with a variety of helpful tools to prevent unnecessary vision loss from diabetes. The group offers the following at no cost:

Focus on Eye Health Expert Series– Prevent Blindness has two episodes in its Focus on Eye Health Expert Series dedicated to diabetes and vision: Kristen Nwanyanwu, MD, MBA, MHS, Associate Professor of Ophthalmology and Visual Science, Yale School of Medicine, discusses “Health Disparities and Diabetes-related Eye Disease,” and Neil M. Bressler, MD, professor of ophthalmology at Johns Hopkins University School of Medicine and Editor in Chief of JAMA Ophthalmology, is featured in “Diabetes and Your Eyes.”

Diabetes + The Eyes Educational Toolkit– Available in English and Spanish, this resource includes Power Point presentations, shareable social media graphics and a dedicated webpage. The Diabetes + The Eyes program, is supported by funding from Regeneron.

Diabetes + The Eyes: Vision Health in Youth Fact Sheet– This new resource provides detailed information on what parents and care partners need to know to help youth with diabetes protect their eye health. This fact sheet was developed with support from UnitedHealthcare. (A Spanish version will be available soon.)

Prevent Blindness and the Focus on Diabetes™ video series- This comprehensive series includes a variety of educational videos designed for consumer audiences. Focus on Diabetes is an eye health initiative of the American Diabetes Association®.

  •     The Patient Perspective: Diabetes-related Eye Disease
  •     Diabetes and Your Eyes ABCs
  •     Newly Diagnosed with Diabetes: What you need to know about your eyes
  •     Introduction to the Diabetes + the Eyes Educational Toolkit

The Gr8 Eye Movement– Prevent Blindness recently partnered with award-winning actress, dancer and director Debbie Allen and Regeneron for the Gr8 Eye Movement, a new disease awareness campaign that aims to address gaps in how people understand the risk of developing certain serious retinal diseases, including diabetes-related macular edema and diabetes-related retinopathy. Information may be found at: Gr8EyeMovement.com.

Diabetes-related Vision Loss and Mental Wellness- Many people who have vision loss or blindness as a result of diabetes also experience a significant, negative impact on their mental health. Prevent Blindness offers the Diabetes, Vision Loss, and Mental Wellness video, and the Diabetes-related Eye Disease and Mental Health fact sheet, available in English and Spanish (supported by funding from Regeneron and VSP Vision).

Vision Integration Library– The Center for Vision and Population Health at Prevent Blindness offers the free “Vision Integration Library: Vision and Eye Health Resource Center at Prevent Blindness.” The comprehensive database with updated resources includes listings of vision health programs and resources specifically intended for those in public health, healthcare, and community service providers.

“We know that the number of people at risk for vision loss and blindness from diabetes continues to climb,” said Jeff Todd, Prevent Blindness president and CEO. “The time is now to take the necessary steps to help those with diabetes, and those at risk for developing diabetes, avoid significant vision impairment by providing educational resources and promoting access to affordable eyecare.”

For more information on the “Diabetes + The Eyes” program, please visit https://preventblindness.org/diabetes-and-eyes-educational-toolkit. For general diabetes-related eye disease information, visit http://preventblindness.org/diabetes or https://preventblindness.org/juvenile-diabetes-and-your-eyes/.

For a free listing of organizations and services that provide financial assistance for vision care in English or Spanish, please visit https://preventblindness.org/vision-care-financial-assistance-information/.

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.

Media Contact

Sarah Hecker, Prevent Blindness, 312.363.6035, [email protected], PreventBlindness.org

SOURCE Prevent Blindness

The Society for Immunotherapy of Cancer Announces Late-Breaking Abstracts and Press Briefing Presented at 38th Annual Meeting


The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2023, more than 1,600, and has announced titles and authors for 30 accepted Late-breaking Abstracts (LBA). The abstracts will be presented at SITC’s upcoming 38th Annual Meeting & Pre-Conference Programs taking place November 1–5, 2023, in San Diego, CA and virtually. SITC also invites you to attend the virtual press briefing of the society’s 38th Annual Meeting (SITC 2023) beginning at 12:00 p.m. PDT on Wednesday, Nov. 1, 2023.

MILWAUKEE, Oct. 25, 2023 /PRNewswire-PRWeb/ — The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2023, more than 1,600, and has announced titles and authors for 30 accepted Late-breaking Abstracts (LBA). The abstracts will be presented at SITC’s upcoming 38th Annual Meeting & Pre-Conference Programs taking place November 1–5, 2023, in San Diego, CA and virtually.

SITC also invites you to attend the virtual press briefing of the society’s 38th Annual Meeting (SITC 2023) beginning at 12:00 p.m. PDT on Wednesday, Nov. 1, 2023.

The abstracts selected for the press briefing represent an array of the top advances in cancer immunotherapy research. Data shared during the press briefing may be embargoed to a later date and time during the Annual Meeting and that information will be shared during the presentation. For more information, please review the SITC 2023 Media Policy.

The schedule of presentations and press briefing presenters are listed in order below:

  1. Abstract #144 – Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types
    Presenter: Darwin Kwok, MS – University of California San Francisco
  2. Abstract #623 – AI-designed personalized neoantigen vaccine, EVX-02, induces robust T-cell responses in melanoma patients
    Presenter: Daniela Kleine-Kohlbrecher, PhD – Evaxion Biotech
  3. Abstract #275 – Inosine endows CAR T cells with features of increased stemness and anti-tumor potency
    Presenter: Dorota Klysz, PhD – Stanford University
  4. Abstract #1514 – In vivo CAR-M: redirecting endogenous myeloid cells with mRNA for cancer immunotherapy (Late-Breaking Abstract)
    Presenter: Michael Klichinsky, PharmD, PhD – Carisma Therapeutics
  5. Abstract #216 – Tissue nanomechanical signature as a novel, clinically translatable predictor of response to immunotherapy combined with low-dose radiation
    Presenter: Sara Nizzero, PhD – ARTIDIS AG, Houston Methodist Research Institute, The University of Texas MD Anderson Cancer Center
  6. Abstract #578 – Anti-PD-1 therapy alters the generation and durability of de novo responses to vaccination in humans
    Presenter: Kelly Burke, MD – Dana-Farber Cancer Institute, Harvard Medical School
  7. Abstract #1519 – Avelumab combined with regorafenib in solid tumors with tertiary lymphoid structures: a phase 2 REGOMUNE trial cohort (Late-Breaking Abstract)
    Presenter: Antoine Italiano, PhD – Institut Bergonié
  8. Abstract #1534 – Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial (Late-Breaking Abstract)
    Presenter: Diwakar Davar, MD – UPMC Hillman Cancer Center

ADDITIONAL DETAILS: 
Participating members of the media will have the opportunity to submit questions for up to three minutes following each presentation. To attend this press briefing, you must register as a member of the press for SITC 2023. To register, please visit https://www.sitcancer.org/2023/press/press-registration. After registration is confirmed, you will receive instructions for the briefing. For more information regarding SITC 2023, please visit the Annual Meeting website at http://www.sitcancer.org/2023.

About SITC 
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, Facebook and YouTube.

Media Contact

Thomas Martin, Society for Immunotherapy of Cancer, 414-271-2456, [email protected], www.sitcancer.org

Twitter

SOURCE Society for Immunotherapy of Cancer



Ziva Health Brings Breathwork and Holistic Wellness Expertise to Market


With the Ziva platform, users share basic information, self-reported health conditions, and choose their health goals and:

  • Receive customized wellness suggestions, including sustainable recommendations and programs
  • Garner content recommendations, programs, and lessons based on self-disclosed health conditions and goals
  • Have the option to leverage AI coaching to answer wellness questions
  • Be held accountable, helping to build routines and daily healthy habits to stick to the recommended programs
  • Leverage wearable technology like the Apple Watch and integrate with the platform to provide better tracking and improve overall health outcomes
  • Access a breathwork module to help with stress, anxiety, sleep issues, improve HRV, improve sports performance and focus

“There’s a wealth of evidence supporting the importance and effectiveness of breathwork to help manage and regulate mental health,” said Parveen Panwar, CEO and Founder of Ziva Health. “Mindful deep breathing coupled with other healthy habits can have a real impact when done regularly and anyone can do it – we’re already seeing breathwork implemented in schools and workplaces around the country. Five minutes a day is all you need. Our platform will guide consumers to easy, sustainable choices with long term benefits.”

As part of the launch, Dr. Michael Kurisu was named Chief Health Officer. Kurisu, a Board Certified Integrative Medicine Physician with a life-long interest in health and healing uses traditional and holistic approaches to treat patients. With a background in osteopathic manipulation treatment (OMT), he focuses on emerging wearable technologies and digital devices as a resource to provide the next era of personalized healthcare.

Serena Poon, a celebrity chef, nutritionist, and longevity wellness expert also joins Ziva’s board of advisors to provide the proper guidance and support to help individuals navigate life’s challenges with clarity and purpose.

“Today, most everyone has a wearable device that can change their health in drastic ways – they just need to unlock its potential,” said Dr. Michael Kurisu, Ziva’s newly appointed Chief Health Officer. “By combining technology with both a traditional and holistic approach, Ziva makes it easy for individuals to enhance their wellness, from warding off disease to getting a better night’s sleep.”

AvantStay and Measured Wellness Clinic are two new partners leveraging the benefits of Ziva for its workforce. Ziva is eyeing a large market opportunity by inspiring people to make healthy lifestyle choices through breathwork that create sustainable changes.

About Ziva Health

Ziva is a digital mental wellness company focused on improving overall mental well-being through the power of breathing. Ziva’s platform is designed to build a happier and healthier you- mind, body, and spirit. Our key value is to provide personalized recommendations and tools to empower people to improve sleep, reduce stress, enhance focus, find calm, ease anxiety and unlock peak performance. Our integrative mental wellness approach is designed to address the root cause using our science-backed,evidence-based approach. Personalized care to improve overall mental wellbeing is offered through our technology coupled with human touch from our coaches. Learn more at www.ziva.health.

1 “Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials,” Scientific Reports, January 9, 2023

Media Contact

Aimee Clark, Dotted Line Communications, 1 (617) 283 0012, [email protected]

SOURCE Ziva Health

Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases, Upcoming Webinar Hosted by Xtalks


To ensure that each transposon is integrated correctly and to demonstrate its orthogonality, they have performed genetic QC by means of Targeted Locus Amplification (TLA) coupled with next-generation sequencing (NGS). This allowed for the identification and genetic characterization of all integration sites of each transposon. Furthermore, by comparing the TLA data of different timepoints they were able to evaluate the genetic stability and integrity of the transposons.

Join this webinar to learn about transposase-mediated genome engineering, genetic quality control and ensuring the genetic stability of orthogonal transposons in the generation of cell lines with Leap-In Transposase® technology.

Join Maya Wright Clark, PhD, Sales and Account Manager, Cergentis; and Mário Pereira, Director of Technologies and Business Development, ATUM, for the live webinar on Thursday, November 9, 2023, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Well Aliments Unveils New Health Supplements for Optimal Wellness


Additionally, it offers products in different packaging forms, such as Bottles, Blisters, Pouches, etc…

Examples of Beauty & Skincare products offered are Creams, Toners, Serums, Cleansers, etc…

“We are thrilled to introduce our new line of health vitamins and supplements,” said Dr. Tarek Eweis, CEO at Well Aliments. “Our team of experts has worked tirelessly to create products that are not only effective but also safe and reliable. We believe that everyone deserves a healthy lifestyle, and that’s precisely what we aim to deliver.”

Well Aliments‘ Dedication to quality extends beyond just its product offerings. As a leading pharmaceuticalvitaminssupplementsskincare & cosmeticshealth & functional food and sports nutrition manufacturer / company. This ensures that customers can trust Well Aliments to deliver top-notch products that meet the highest industry standards & regulations. To name a few of the certifications, Well Aliments has, FDA (Food and Drug Administration), GMP (Good Manufacturing Practices), Kosher, Halal, etc…

“Our mission is to improve the health of people around the world” Dr. Tarek Eweis added. “We understand that the health and wellness industry can sometimes have a huge number of choices, but Well Aliments stands out as a company you can trust, as it’s trusted by customers in numerous countries worldwide. We encourage health and wellness retailers and nutritional supplement producers to join us as valued partners in this journey.”

Experience the Well Aliments difference by exploring our wide range of health supplements today. Join us in our mission to promote well-being and enhance the quality of life for individuals everywhere. Together, we can achieve remarkable things.

Well Aliments is a leader in the health and wellness industry, specializing in Pharmaceuticals, Vitamins & Supplements, Skincare & Cosmetics, and Sports Nutrition manufacturing. With a strong commitment to quality and a passion for improving lives, Well Aliments is dedicated to providing high-quality health supplements to meet the diverse needs of customers.

To learn more about Well Aliments and explore our range of health products & services, please visit our website at https://wellailments.com Join us in our mission to promote optimal wellness and become a valued partner in our journey.

Media Contact

Quency Powell, Well Aliments LLC, 1 667-305-0585 , [email protected], https://wellaliments.com

SOURCE Well Aliments LLC

Accelerating Drug Discovery by Hypothesis and Synthesis Management Platform, Upcoming Webinar Hosted by Xtalks


In this webinar, Dóra will explore how a hypothesis and synthesis management platform can streamline data-driven decision-making and enhance the efficiency of drug discovery projects.

Join this webinar and discover how to overcome various challenges of compound synthesis and decision-making in drug discovery.

Join Dóra Barna, PhD, Principal Application Scientist, Chemaxon, for the live webinar on Friday, November 10, 2023, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Accelerating Drug Discovery by Hypothesis and Synthesis Management Platform.

ABOUT CHEMAXON

Trusted by over one million active users, Chemaxon is renowned for industry-leading software supporting scientific discovery with calculation, search and drawing tools.

Our applications are widely used in life sciences R&D and education. We work with a variety of industries, counting most major pharmaceutical companies among our clients. Our offices are located in Budapest, Basel, Boston and San Diego, with distributors around the world.

To learn about Chemaxon visit: https://chemaxon.com
For information about Design Hub visit: https://chemaxon.com/design-hub

Contact:
Viola Zoldy
[email protected]

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks